In August, the chief executive officer of Medtronic, the world's second-largest public medtech company by revenue, sat down for a wide ranging interview with MD+DI - everything from accountable care and risk-based contracts, to globalization and various therapies that the company has developed.
Over the next few days and weeks, we will present video snippets of that interview.
In the first of these, Omar Ishrak talks about innovation and responds to the question that large companies appear to be simply buying up innovative companies instead of developing something novel internally.
Arundhati Parmar is senior editor at MD+DI. Reach her at [email protected] and on Twitter @aparmarbb
[Photo Credit: Arterys YouTube]
|Learn more about the medtech industry trends at MD&M West, Feb. 9-11, at the Anahein Convention Center, Anaheim, California.|